Teva CEO responds to 25% share price fall
Since the publication of its financial results for 2024 at the end of January, the share price Teva Pharmaceutical Industries Ltd. (NYSE: Tifa;; level: Tiva) He fought for recovery, as about $ 6 billion from the maximum…